Regulatory considerations and guidelines for RNA-based therapeutics
As of my knowledge cutoff in September 2021, the development and use of RNA-based therapeutics, like any new drug, are subject to rigorous regulatory oversight to ensure their safety and efficacy. Here are some of the key considerations and guidelines: 1. Preclinical Testing Before an RNA-based therapeutic can be tested in humans, it must undergo…
